Impact of Proton Pump Inhibitors and Dual Antiplatelet Therapy Cessation on Outcomes Following Percutaneous Coronary Intervention: Results From the PARIS Registry

Chandrasekhar, J; Bansilal, S; Baber, U; Sartori, S; Aquino, M; Farhan, S; Vogel, B; Faggioni, M; Giustino, G; Ariti, C; Colombo, A; Chieffo, A; Kini, A; Saporito, R; Gibson, CM; Witzenbichler, B; Cohen, D; Moliterno, D; Stuckey, T; Henry, T; Pocock,

Mehran, R (reprint author), Mt Sinai Sch Med, One Gustave L Levy Pl,Box 1030, New York, NY 10029 USA.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2017; 89 (7): E217

Abstract

Background: Proton pump inhibitors (PPI) may decrease the availability of clopidogrel by competitive antagonism, leading to a potential increase in is......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索